SKI Market

Indian Indices

Sensex

82,276.07 50.15
( 0.06%)

Global Indices

Nasdaq

49,202.49 377.42
(0.77%)

Dow Jones

6,910.52 51.77
(0.75%)

Hang Seng

58,650.11 1,329.02
(2.32%)

Nikkei 225

10,802.86 122.27
(1.14%)

Forex

USD-INR

90.87 0.15
(0.16%)

EUR-INR

107.26 0.37
(0.35%)

GBP-INR

122.73 0.47
(0.39%)

JPY-INR

0.59 0.00
(0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Niyogin Fintech Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

538772

INE480D01010

32.090983

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

383

468.69

EPS(TTM)

Face Value()

Div & Yield %

0.11

Back

Panacea Biotec reports consolidated net loss of Rs 13.92 crore in the September 2025 quarter

Nov 15,2025

Net loss of Panacea Biotec reported to Rs 13.92 crore in the quarter ended September 2025 as against net profit of Rs 4.80 crore during the previous quarter ended September 2024. Sales declined 4.22% to Rs 141.13 crore in the quarter ended September 2025 as against Rs 147.35 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	141.13	147.35	-4
OPM %	-12.61	4.75	-
PBDT	-13.53	10.67	PL
PBT	-21.87	1.99	PL
NP	-13.92	4.80	PL

82,276.07 50.15 ( 0.06%)

49,202.49 377.42 (0.77%)

6,910.52 51.77 (0.75%)

58,650.11 1,329.02 (2.32%)

10,802.86 122.27 (1.14%)

90.87 0.15 (0.16%)

107.26 0.37 (0.35%)

122.73 0.47 (0.39%)

0.59 0.00 (0.51%)